DermTech, Inc. (DMTK)

1 member of Congress has disclosed 5 trades in DermTech, Inc. (DMTK) via STOCK Act filings. The most recent disclosure was a sale by Tom Malinowski on 27 January 2021. Aggregate disclosed activity totals roughly $24K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for DMTK
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for DMTK

5 transactions
Compliance: 60%
Tom Malinowski27 Jan 20215 Mar 2021SaleStock$1,001 - $15,000N/A
Tom Malinowski27 Jan 202113 Aug 2022SaleStock$1,001 - $15,000N/A
Tom Malinowski11 Jan 202126 Aug 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski11 Jan 20215 Mar 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski11 Jan 202113 Aug 2022PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$3.29M

Volume

3.4M

Beta

2.42

P/E Ratio

-0.04

Fundamentals

EPS

$-2.65

Div. Yield

-

Open

$0.10

Day Range

$0.09 – $0.10

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
Country
US
CEO
Bret Christensen
IPO Date
2017-08-10

DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the dia...

Earnings

Recent Quarters

Q2 20241 Aug
EPS$-0.99
Miss 90.4%
Q1 202414 May
EPS$-0.58
Beat 6.5%
Q4 202329 Feb
EPS$-0.56
Miss 3.7%
Q3 20232 Nov
EPS$-0.57
Beat 16.2%
Q2 20233 Aug
EPS$-0.99
Miss 4.2%
Q1 20234 May
EPS$-1.02
Miss 13.3%
Q4 20222 Mar
EPS$-0.93
Beat 3.1%
Q3 20223 Nov
EPS$-0.96
Beat 3.0%
Q2 20228 Aug
EPS$-0.99
Beat 2.9%
Q1 20223 May
EPS$-1.01
Miss 18.8%
Q4 20211 Mar
EPS$-0.88
Miss 20.6%
Q3 20219 Nov
EPS$-0.68
Miss 4.6%
Q2 20214 Aug
EPS$-0.48
Beat 11.1%
Q1 202113 May
EPS$-0.49
Miss 4.3%
Q4 20204 Mar
EPS$-0.48
Beat 11.1%
Q3 202010 Nov
EPS$-0.50
Beat 13.8%
Q2 20205 Aug
EPS$-0.58
Miss 56.8%
Q1 202013 May
EPS$-0.53
Miss 15.2%
Q4 201911 Mar
EPS$-0.08
Beat 80.0%
Q3 20197 Nov
EPS$-0.80
Q2 201913 Aug
EPS$-0.02
Q1 201914 Jun
EPS$-0.00
Q4 201814 Feb
EPS$0.10
Q3 201814 Nov
EPS$0.00
Q2 201810 Aug
EPS$0.09
Q1 201829 Jun
EPS$0.08
Q4 201713 Feb
EPS$0.05
Q3 201713 Nov
EPS$0.05
Q2 201714 Aug
EPS$-0.01
Q2 201630 Sept
EPS$0.00
Q1 201630 Jun
EPS$0.00
Q1 201430 Jun
EPS$-0.15
Q4 201331 Mar
EPS$-0.17
Q3 201331 Dec
EPS$-0.29
Q2 201330 Sept
EPS$-0.29
Q1 201330 Jun
EPS$-0.29
Q4 201231 Mar
EPS$-0.21

No dividend data available for this stock.

Stock Splits

Split History

30 Aug 2019Reverse Split
Ratio1:2

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about DMTK

Which members of Congress have traded DMTK?
1 member of Congress has disclosed 5 trade in DermTech, Inc. (DMTK) under the STOCK Act: Tom Malinowski.
When was DMTK most recently disclosed by Congress?
The most recent DMTK disclosure was a sale by Tom Malinowski on 27 January 2021.
What is the total disclosed congressional trading volume for DMTK?
Members of Congress have disclosed approximately $24K in DMTK purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in DMTK?
This DMTK page updates as soon as new STOCK Act disclosures are filed for DermTech, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.